Developing and manufacturing custom recombinant antibodies for R&D

In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding its product offerings into the European market and outlines its process for developing and manufacturing custom recombinant antibodies for their clients.

Related Keywords

China ,Germany ,Beijing ,United States ,United Kingdom ,Switzerland ,Chinese ,American ,British ,Swiss ,Alex Smith ,Liangzhi Xie ,Zhang Lin Lintechnical Specialistsino ,Linlin Zhang ,Sino Biological Inc Apr ,Sino Biological Inc ,Sponsored Content ,Zhang Lin Lintechnical Specialistsino Biological ,Sino Biological Europe ,Sino Biological ,North American ,Sino Biological Europe Her ,Antibodies ,Manufacturing ,Ntibody ,Ntigen ,Essay ,Fell ,Cell Sorting ,Covid 19 ,Ytokines ,Iagnostics ,C Receptor ,Gene ,High Throughput ,Immunization ,Influenza ,Mammalian Cells ,Olecule ,Monoclonal Antibody ,Pandemic ,Mh ,Protein ,Protein Expression ,Eagents ,Eceptor ,Research ,Cars ,Ars Cov 2 ,Spike Protein ,Structural Biology ,Vaccine ,Virus ,